Manulife (Manufacturers Life Insurance)
ABEO icon

Manulife (Manufacturers Life Insurance)’s Abeona Therapeutics ABEO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.8K Sell
12,901
-750
-5% -$3.75K ﹤0.01% 2723
2025
Q4 		$71.9K Sell
13,651
-1,761
-11% -$8.87K ﹤0.01% 2769
2025
Q3 		$81.4K Sell
15,412
-1,501
-9% -$9.52K ﹤0.01% 2813
2025
Q2 		$96.1K Buy
+16,913
New +$96.3K ﹤0.01% 2765
2020
Q4 		– Sell
-1,550
Closed -$40K – 2982
2020
Q3 		$40K Hold
1,550
– – ﹤0.01% 2893
2020
Q2 		$111K Buy
1,550
+232
+18% +$16K ﹤0.01% 2718
2020
Q1 		$69K Buy
1,318
+882
+202% +$58.9K ﹤0.01% 2671
2019
Q4 		$36K Sell
436
-501
-53% -$35.4K ﹤0.01% 2853
2019
Q3 		$58K Hold
937
– – ﹤0.01% 2876
2019
Q2 		$112K Buy
937
+433
+86% +$72.6K ﹤0.01% 2867
2019
Q1 		$93K Buy
504
+78
+18% +$13.9K ﹤0.01% 2583
2018
Q4 		$76K Sell
426
-57
-12% -$12.4K ﹤0.01% 2461
2018
Q3 		$155K Sell
483
-470
-49% -$167K ﹤0.01% 2825
2018
Q2 		$381K Buy
953
+85
+10% +$37.1K ﹤0.01% 2594
2018
Q1 		$311K Sell
868
-15
-2% -$5.57K ﹤0.01% 2695
2017
Q4 		$350K Buy
883
+97
+12% +$40.1K ﹤0.01% 2574
2017
Q3 		$334K Buy
786
+778
+9,725% +$209K ﹤0.01% 2568
2017
Q2 		$1K Buy
8
+3
+60% +$409 ﹤0.01% 4186
2017
Q1 		$1K Hold
5
– – ﹤0.01% 4000
2016
Q4 		$1K Hold
5
– – ﹤0.01% 4158
2016
Q3 		$1K Hold
5
– – ﹤0.01% 4111
2016
Q2 		$0 Sell
5
-101
-95% -$6.9K ﹤0.01% 4245
2016
Q1 		$7K Buy
106
+101
+2,020% +$6.69K ﹤0.01% 3702
2015
Q4 		$0 Hold
5
– – ﹤0.01% 4004
2015
Q3 		$1 Hold
5
– – ﹤0.01% 3895
2015
Q2 		$1 Buy
+5
New +$751 ﹤0.01% 3877

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ABEO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Abeona Therapeutics (ABEO) stake by 5.5% in Q1 2026, selling an estimated $3.75K and leaving 12,901 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2723.

Manulife (Manufacturers Life Insurance) first reported a position in ABEO in Q2 2015 and has held it in 26 quarters since. The position peaked at $381K in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 12,901 shares of Abeona Therapeutics worth $57.8K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 750 Abeona Therapeutics shares in Q1 2026, an estimated $3.75K.
  • Abeona Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2723 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 26 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Abeona Therapeutics position peaked at $381K in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.